Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kos expands research efforts with Triad investment
The equity investment builds on an ongoing sponsored research arrangement in which, on behalf of Kos, Triad is designing and synthesizing certain new chemical entities that regulate HDL
The equity investment builds on an ongoing sponsored research arrangement in which, on behalf of Kos, Triad is designing and synthesizing certain new chemical entities that regulate HDL
NPS is extending the time it will take to prepare the new drug application (NDA) in light of European deadlines and filing requirements of its partner Nycomed, and
Previous experimental research has shown that low doses of Alferon N, the only natural alpha IFN cocktail available in the US, added to the water and food supply
Doxil (doxorubicin HCl liposome injection) is now approved for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy. Doxil originally received
Flovent HFA (fluticasone propionate HFA) inhalation aerosol will become available in pharmacies from March 1. This new formulation uses a more ozone friendly propellant than CFC, namely hydrofluoroalkane
The phase I trial is a dose escalating trial in which volunteers will receive three monthly intramuscular doses of vaccine. The trial is designed to confirm that the
Synthon will co-promote Lithobid through its sales force of approximately 50 sales representatives to high volume prescribing psychiatrists across the US. Financial terms of the agreement were not
The trial in India is part of a multi-country phase I clinical development program for tgAAC09, an investigational recombinant adeno-associated viral vector (rAAV)-based HIV/AIDS vaccine candidate, that is
Eloxatin (oxaliplatin) injection is a clear, preservative-free solution available in 50mg and 100mg doses. Eloxatin injection offers additional benefit and convenience as it involves fewer steps in the
Under the agreement, St Louis, Missouri-based Tripos will identify and optimize backup series for one of BioTie’s key drug discovery programs. Tripos will then rapidly create compound libraries